University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages

dc.contributor.authorMelendez-Torres, G. J.
dc.contributor.authorArmoiry, Xavier
dc.contributor.authorCourt, Rachel
dc.contributor.authorPatterson, Jacoby
dc.contributor.authorKan, Alan
dc.contributor.authorAuguste, Peter
dc.contributor.authorMadan, Jason
dc.contributor.authorCounsell, Carl
dc.contributor.authorCiccarelli, Olga
dc.contributor.authorClarke, Aileen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2018-10-17T15:20:24Z
dc.date.available2018-10-17T15:20:24Z
dc.date.issued2018-10-03
dc.descriptionThis work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. Aileen Clarke and G.J. Melendez-Torres are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, NICE or the Department of Health and Social Care.en
dc.description.statusPeer revieweden
dc.format.extent863759
dc.identifier140000548
dc.identifier1e0986b2-175c-49bd-9576-cb55fb84357c
dc.identifier85054381653
dc.identifier.citationMelendez-Torres, G J, Armoiry, X, Court, R, Patterson, J, Kan, A, Auguste, P, Madan, J, Counsell, C, Ciccarelli, O & Clarke, A 2018, 'Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages', BMC Neurology, vol. 18, 162. https://doi.org/10.1186/s12883-018-1162-9en
dc.identifier.doi10.1186/s12883-018-1162-9
dc.identifier.issn1471-2377
dc.identifier.otherRIS: urn:E9C520A36BFECC63274148314181CD8F
dc.identifier.otherRIS: Melendez-Torres2018
dc.identifier.otherORCID: /0000-0001-6622-7839/work/164505693
dc.identifier.urihttp://hdl.handle.net/2164/11266
dc.identifier.vol18en
dc.language.isoeng
dc.relation.ispartofBMC Neurologyen
dc.subjectmultiple sclerosisen
dc.subjectclinically isolated syndromeen
dc.subjectbeta-interferonen
dc.subjectglatiramer acetateen
dc.subjectsystematic reviewen
dc.subjecteconomic evaluationen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRen
dc.titleComparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosagesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Comparative_effectiveness_of_beta_interferons_and_glatiramer_acetate_for_relapsing_remitting_multiple_sclerosis.pdf
Size:
843.51 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: